Alex J. Eustace

1.8k citations

52 papers · 1.2k indexed · 1 hit paper · h-index 20

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis

Papers in

Oncology 35
- HER2/EGFR in Cancer Research 23
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 6
Cancer Research 9
- Cancer Genomics and Diagnostics 4

Co-authors: John Crown Martin Clynes Norma O’Donovan Martina S.J. McDermott Denis M. Collins Laura Breen Britta Stordal Bryan T. Hennessy
Journals: Journal of Clinical Oncology (8 papers)British Journal of Cancer (6 papers)Investigational New Drugs (3 papers)Annals of Oncology (3 papers)Cancers (3 papers)
Partner nations: Ireland United States United Kingdom

In The Last Decade

Alex J. Eustace

49 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

CARBON DOTS: Bioimaging and Anticancer Drug Delivery 2024 · 66 citations

Peers

Countries citing papers authored by Alex J. Eustace

Since Specialization

Citations

This map shows the geographic impact of Alex J. Eustace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex J. Eustace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex J. Eustace more than expected).

Fields of papers citing papers by Alex J. Eustace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex J. Eustace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex J. Eustace. The network helps show where Alex J. Eustace may publish in the future.

Co-authors

The 25 scholars most cited alongside Alex J. Eustace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alex J. Eustace Line = papers co-authored together Alex J. Eustace links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study Acta Oncologica ·Rosalba Miceli, Hanna Eriksson, Giuseppe Lo Russo, Salvatore Alfieri, Maria Moksnes Bjaanæs, Filippo Pietrantonio, Loris De Cecco, Arsela Prelaj, Claudia Proto, Johan Franzén, D. McDonnell, José Javier Berenguer Pina, Teresa Beninato, Laura Mazzeo, Patrizia Giannatempo, Elena Verzoni, John Crown, Åslaug Helland, Alex J. Eustace	2024	3
2	Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference Cancers ·Seodhna M. Lynch, Aisling B. Heeran, Caoimbhe Burke, Niamh Lynam‐Lennon, Alex J. Eustace, Kellie Dean, Tracy Robson, Arman Rahman, Simone Marcone	2024	2
3	CARBON DOTS: Bioimaging and Anticancer Drug Delivery Chemistry - A European Journal ·Michał Bartkowski, Yingru Zhou, Mustafa Nabil Amin Mustafa, Alex J. Eustace, Silvia Giordani Hit paper breakdown →	2024	66
4	Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer PLoS ONE ·Sandra Roche, Patricia Gaule, Deirdre Winrow, Nupur Mukherjee, Fiona O’Neill, Neil T. Conlon, Justine Meiller, Denis M. Collins, Alexandra Canonici, Mohammed Ibrahim Fawsi, Alejandra Estepa‐Fernández, Stephen F. Madden, John Crown, Norma O’Donovan, Alex J. Eustace	2023	6
5	Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy British Journal of Cancer ·Nicola Gaynor, Alfonso Blanco, Stephen F. Madden, Barry Moran, Jean M. Fletcher, Damien Kaukonen, Javier Sánchez Ramírez, Alex J. Eustace, Martina S.J. McDermott, Alexandra Canonici, Sinéad Toomey, Ausra Teiserskiene, Bryan T. Hennessy, Norma O’Donovan, John Crown, Denis M. Collins	2023	6
6	1795P Gender difference in side effects of immunotherapy: A possible clue to optimize cancer treatment Annals of Oncology ·Rosalba Miceli, Hanna Eriksson, Alex J. Eustace, Giuseppe Lo Russo, J. Ballot, Cristiana Bergamini, Maria Moksnes Bjaanæs, Francesca Corti, Loris De Cecco, L. Frisardi, Patrizia Giannatempo, Elena Verzoni, Åslaug Helland, John Crown	2021	4
7	Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A Investigational New Drugs ·Laura Breen, Patricia Gaule, Alexandra Canonici, Naomi Walsh, Denis M. Collins, Mattia Cremona, Bryan T. Hennessy, Michael J. Duffy, John Crown, N. O' Donovan, Alex J. Eustace	2020	10
8	Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells Cancers ·Patricia Gaule, Nupur Mukherjee, B. Corkery, Alex J. Eustace, Kathy Gately, Sandra Roche, Robert O’Connor, Kenneth J. O’Byrne, Naomi Walsh, Michael J. Duffy, John Crown, Norma O’Donovan	2019	19
9	The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells Investigational New Drugs ·Alexandra Canonici, Z. Qadir, Neil T. Conlon, Denis M. Collins, Neil A. O’Brien, Naomi Walsh, Alex J. Eustace, Norma O’Donovan, John Crown	2018	19
10	Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH) PLoS ONE ·Damien Côté, Alex J. Eustace, Sinéad Toomey, Mattia Cremona, Małgorzata Milewska, Simon J. Furney, Aoife Carr, Joanna Fay, Elaine W. Kay, Susan Kennedy, John Crown, Bryan T. Hennessy, Stephen F. Madden	2018	11
11	The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer Oncotarget ·Sinéad Toomey, Stephen F. Madden, Simon J. Furney, Yue Fan, Mark McCormack, C. P. Stapleton, Mattia Cremona, Gianpiero L. Cavalleri, Małgorzata Milewska, Naomi Elster, Aoife Carr, Joanna Fay, Elaine W. Kay, Susan Kennedy, John Crown, William M. Gallagher, Bryan T. Hennessy, Alex J. Eustace	2016	10
12	Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma International Journal of Oncology ·Thamir Mahgoub, Alex J. Eustace, Denis M. Collins, Naomi Walsh, Norma O’Donovan, John Crown	2015	17
13	Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer Oncogene ·Dearbhaile Catherine Collins, Sinéad Cocchiglia, Paul Tibbitts, Gemma Solon, F Bane, Jean McBryan, Achim Treumann, Alex J. Eustace, Bryan T. Hennessy, A Hill, Leonie S. Young	2014	23
14	A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib Breast Cancer Research and Treatment ·Naomi Elster, Mattia Cremona, Clare Morgan, Sinéad Toomey, Aoife Carr, A O’Grady, Bryan T. Hennessy, Alex J. Eustace	2014	38
15	Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer British Journal of Cancer ·Benjamin Hunter, Alex J. Eustace, Joely J. Irlam, Helen Valentine, Helen Denley, Ken Oguejiofor, R Swindell, Peter Hoskin, Ananya Choudhury, Catharine West	2014	34
16	Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours Breast Cancer Research and Treatment ·Brigid C. Browne, Alex J. Eustace, Susan Kennedy, Neil A. O’Brien, Kasper Pedersen, Martina S.J. McDermott, Annemarie Larkin, Jo Ballot, Thamir Mahgoub, Francesco Sclafani, Stephen F. Madden, John Kennedy, Michael J. Duffy, John Crown, Norma O’Donovan	2012	32
17	Artificial neural networks in metabolomic studies of human lung carcinoma cell lines by in vitro 1H nuclear magnetic resonance of whole cells BioMed Research International ·Dermot F. Brougham, Galya Ivanova, Michael Gottschalk, Dennis M Collins, Alex J. Eustace, Robert O Connor, Josef Havel	2011	4
18	Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis British Journal of Cancer ·Naomi Walsh, Susan Kennedy, A. Larkin, Dimitrios Tryfonopoulos, Alex J. Eustace, Thamir Mahgoub, Caroline Conway, Irene Oglesby, Denis M. Collins, J. Ballot, Wei Ooi, G. Gullo, Martin Clynes, J. Crown, Lorraine O’Driscoll	2010	32
19	Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells British Journal of Cancer ·Darren L. Roberts, Kaye J. Williams, R. Cowen, Monika Baráthová, Alex J. Eustace, S Brittain-Dissont, Michael J. Tilby, D. Graham Pearson, Christopher J. Ottley, Ian J. Stratford, Caroline Dive	2009	42
20	The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells BMC Cancer ·Sharon A. Glynn, DERMOT A. O'SULLIVAN, Alex J. Eustace, Martin Clynes, Norma O’Donovan	2008	88

About Alex J. Eustace

Alex J. Eustace is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Melanoma and MAPK Pathways (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Peptidase Inhibition and Analysis (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Cancer Research (347 citations), Oncology (429 citations), Molecular Biology (688 citations), Pulmonary and Respiratory Medicine (163 citations) and Biotechnology (38 citations). Alex J. Eustace has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include John Crown, Martin Clynes, Norma O’Donovan, Martina S.J. McDermott, Denis M. Collins, Laura Breen, Britta Stordal, Bryan T. Hennessy, Sinéad Toomey and Joely J. Irlam. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Investigational New Drugs, Annals of Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact